5 Common Pitfalls in Pharma Contract Manufacturing (And How to Avoid Them)

 Pharma contract manufacturing is a smart way for companies to produce high-quality DGCI-approved medicines without establishing a full-fledged manufacturing facility. This service has become a necessity for pharmaceutical companies that cannot afford to invest in in-house manufacturing services. Thus, they outsource their production requirements to top pharma contract companies in India and ensure the delivery of quality medicines to label as their own brand name. However, there are some common pitfalls in contract manufacturing if not managed wisely. Let's understand the 5 most common pitfalls of pharmaceutical contract manufacturing systems.

1. Choosing the Wrong Manufacturing Partner

The biggest mistake a pharmaceutical brand can commit is to collaborate with the wrong pharma contractor for manufacturing processes. If you mistakenly select an unethical or low grade manufacturing company due to the attraction of low costing, that would be devastating for your brand image and credibility.


How to avoid it:---

Always check certifications, past work, client reviews, and production capacity. Visit the facility if possible. Choose a partner who follows strict quality guidelines.

2. Ignoring Quality Compliance

Quality is the non-negotiable instrument in pharmaceuticals and manufacturing services. Adherence to WHO-GMP, ISO and DGCI certifications is mandatory regulatory requirements in pharmaceuticals. Moreover, the entire healthcare fraternity never promotes or prescribes non-compliance medications. 


How to avoid it:---

Ensure your manufacturer has a clean environment for manufacturing and production. They must adhere to GMP guidelines to process quality medicines. Above all regular audits are extremely necessary to ensure quality standards. 

3. Lack of Clear Communication

Miscommunication can cause malfunctions in production processes. Both parties should be clear about drug formulations, quality standards, labeling, packaging quality, and above all, pricing.


How to avoid it:---

Maintain clear and regular communication with your manufacturing partner. Share detailed requirements for formulation, packaging, and timelines. Written agreements help avoid confusion.

4. Hidden Costs and Budget Issues

Hidden costs and overcharging are common issues in contract manufacturing. Thus, be extremely careful about the financial aspects of manufacturing services. Sometimes companies face unexpected costs due to unclear pricing or additional charges.


How to avoid it:---

Get everything in writing regarding cost of production and services. 

Discuss all financial aspects in advance, including production, packaging, transportation, and taxes. A transparent agreement helps you manage your budget better and avoid surprises.

5. Delays in Delivery

Delivery mismanagement is a common issue for many third-party pharma manufacturers in India. Therefore, find a production partner that has a swift and guaranteed delivery network. Many companies in India, like Casca Remedies, have a 100% record for timely delivery for pharmaceutical production orders.


How to avoid it:---

Choose a manufacturer with a strong supply chain and proven delivery record. Set clear timelines and include penalty clauses for delays in your contract.

Conclusion

There are hundreds of pharma contract manufacturing companies in India offering quality pharmaceutical production and services. However, only a few work flawlessly and offer 100% satisfaction to their clients. One of those companies is Casca Remedies. With a record of more than 500 satisfied third-party manufacturing clients across India, this company has no red flags in its manufacturing infrastructure. Therefore, any pharmaceutical brand and company can confidently outsource their production requirements to Casca Remedies.

Comments

Popular posts from this blog

How to Choose The Best Third Party Pharma Manufacturing In India

Third-party manufacturing pharma company: A great assistance to international companies

Need of third party manufacturing in pharmaceuticals: The economic aspect!